UniProt ID | ARP2_HUMAN | |
---|---|---|
UniProt AC | P61160 | |
Protein Name | Actin-related protein 2 | |
Gene Name | ACTR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 394 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell projection . | |
Protein Description | Functions as ATP-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the pointed end of the daughter actin filament.. | |
Protein Sequence | MDSQGRKVVVCDNGTGFVKCGYAGSNFPEHIFPALVGRPIIRSTTKVGNIEIKDLMVGDEASELRSMLEVNYPMENGIVRNWDDMKHLWDYTFGPEKLNIDTRNCKILLTEPPMNPTKNREKIVEVMFETYQFSGVYVAIQAVLTLYAQGLLTGVVVDSGDGVTHICPVYEGFSLPHLTRRLDIAGRDITRYLIKLLLLRGYAFNHSADFETVRMIKEKLCYVGYNIEQEQKLALETTVLVESYTLPDGRIIKVGGERFEAPEALFQPHLINVEGVGVAELLFNTIQAADIDTRSEFYKHIVLSGGSTMYPGLPSRLERELKQLYLERVLKGDVEKLSKFKIRIEDPPRRKHMVFLGGAVLADIMKDKDNFWMTRQEYQEKGVRVLEKLGVTVR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDSQGRKV -------CCCCCCEE | 11.46 | 25944712 | |
3 | Phosphorylation | -----MDSQGRKVVV -----CCCCCCEEEE | 32.98 | 27251275 | |
7 | Malonylation | -MDSQGRKVVVCDNG -CCCCCCEEEEECCC | 46.32 | 26320211 | |
7 | Acetylation | -MDSQGRKVVVCDNG -CCCCCCEEEEECCC | 46.32 | 27452117 | |
7 | Ubiquitination | -MDSQGRKVVVCDNG -CCCCCCEEEEECCC | 46.32 | 33845483 | |
11 | S-palmitoylation | QGRKVVVCDNGTGFV CCCEEEEECCCCCEE | 1.96 | 29575903 | |
19 | Methylation | DNGTGFVKCGYAGSN CCCCCEEECCCCCCC | 21.49 | - | |
19 | Ubiquitination | DNGTGFVKCGYAGSN CCCCCEEECCCCCCC | 21.49 | 21963094 | |
22 | Phosphorylation | TGFVKCGYAGSNFPE CCEEECCCCCCCCCH | 19.77 | 20090780 | |
43 | Phosphorylation | VGRPIIRSTTKVGNI CCCCEEECCCEECCE | 29.98 | 23312004 | |
44 | Phosphorylation | GRPIIRSTTKVGNIE CCCEEECCCEECCEE | 22.31 | 23312004 | |
45 | Phosphorylation | RPIIRSTTKVGNIEI CCEEECCCEECCEEE | 25.61 | 23312004 | |
46 | Ubiquitination | PIIRSTTKVGNIEIK CEEECCCEECCEEEE | 48.51 | 23000965 | |
53 | Ubiquitination | KVGNIEIKDLMVGDE EECCEEEEEEECCCH | 31.83 | 21906983 | |
56 | Sulfoxidation | NIEIKDLMVGDEASE CEEEEEEECCCHHHH | 4.55 | 21406390 | |
62 | Phosphorylation | LMVGDEASELRSMLE EECCCHHHHHHHHHH | 34.81 | 28674151 | |
66 | Phosphorylation | DEASELRSMLEVNYP CHHHHHHHHHHCCCC | 40.10 | 21406692 | |
67 (in isoform 2) | Phosphorylation | - | 2.75 | - | |
72 | Phosphorylation | RSMLEVNYPMENGIV HHHHHCCCCCCCCCC | 14.77 | 21406692 | |
86 | Ubiquitination | VRNWDDMKHLWDYTF CCCHHHCHHHHHHCC | 42.41 | 21906983 | |
86 | Acetylation | VRNWDDMKHLWDYTF CCCHHHCHHHHHHCC | 42.41 | 26822725 | |
91 | Ubiquitination | DMKHLWDYTFGPEKL HCHHHHHHCCCHHHC | 7.74 | 21963094 | |
91 | Phosphorylation | DMKHLWDYTFGPEKL HCHHHHHHCCCHHHC | 7.74 | 28152594 | |
92 | Phosphorylation | MKHLWDYTFGPEKLN CHHHHHHCCCHHHCC | 21.46 | 28152594 | |
97 | Ubiquitination | DYTFGPEKLNIDTRN HHCCCHHHCCCCCCC | 50.39 | 21906983 | |
102 | Ubiquitination | PEKLNIDTRNCKILL HHHCCCCCCCCEEEE | 21.71 | 21963094 | |
106 | Ubiquitination | NIDTRNCKILLTEPP CCCCCCCEEEEECCC | 39.68 | 27667366 | |
110 | Phosphorylation | RNCKILLTEPPMNPT CCCEEEEECCCCCCC | 42.89 | 20068231 | |
111 | Ubiquitination | NCKILLTEPPMNPTK CCEEEEECCCCCCCC | 47.58 | 27667366 | |
114 | Sulfoxidation | ILLTEPPMNPTKNRE EEEECCCCCCCCCHH | 15.98 | 30846556 | |
117 | Phosphorylation | TEPPMNPTKNREKIV ECCCCCCCCCHHHHH | 35.63 | 23401153 | |
118 | Acetylation | EPPMNPTKNREKIVE CCCCCCCCCHHHHHH | 56.09 | 25953088 | |
118 | Ubiquitination | EPPMNPTKNREKIVE CCCCCCCCCHHHHHH | 56.09 | 23000965 | |
118 | Neddylation | EPPMNPTKNREKIVE CCCCCCCCCHHHHHH | 56.09 | 32015554 | |
122 | Ubiquitination | NPTKNREKIVEVMFE CCCCCHHHHHHHHHE | 49.14 | 23000965 | |
122 (in isoform 2) | Phosphorylation | - | 49.14 | 27251275 | |
123 | Ubiquitination | PTKNREKIVEVMFET CCCCHHHHHHHHHEE | 2.47 | 23000965 | |
123 | Neddylation | PTKNREKIVEVMFET CCCCHHHHHHHHHEE | 2.47 | 32015554 | |
127 | Ubiquitination | REKIVEVMFETYQFS HHHHHHHHHEECCCC | 1.27 | 23000965 | |
195 | Ubiquitination | DITRYLIKLLLLRGY HHHHHHHHHHHHHCC | 30.41 | 21906983 | |
200 | Ubiquitination | LIKLLLLRGYAFNHS HHHHHHHHCCCCCCC | 35.73 | 22053931 | |
202 | Phosphorylation | KLLLLRGYAFNHSAD HHHHHHCCCCCCCCC | 11.11 | 23312004 | |
207 | Phosphorylation | RGYAFNHSADFETVR HCCCCCCCCCHHHHH | 30.55 | 28348404 | |
212 | Phosphorylation | NHSADFETVRMIKEK CCCCCHHHHHHHHHH | 17.26 | 23312004 | |
212 (in isoform 2) | Phosphorylation | - | 17.26 | 27251275 | |
217 | Ubiquitination | FETVRMIKEKLCYVG HHHHHHHHHHHHCCC | 39.18 | 22817900 | |
219 | Acetylation | TVRMIKEKLCYVGYN HHHHHHHHHHCCCCC | 38.56 | 25953088 | |
219 | Ubiquitination | TVRMIKEKLCYVGYN HHHHHHHHHHCCCCC | 38.56 | 21906983 | |
222 | Ubiquitination | MIKEKLCYVGYNIEQ HHHHHHHCCCCCCHH | 13.82 | 22817900 | |
222 | Phosphorylation | MIKEKLCYVGYNIEQ HHHHHHHCCCCCCHH | 13.82 | 28152594 | |
224 | Ubiquitination | KEKLCYVGYNIEQEQ HHHHHCCCCCCHHHH | 5.36 | 21963094 | |
225 | Phosphorylation | EKLCYVGYNIEQEQK HHHHCCCCCCHHHHH | 11.70 | 28152594 | |
237 | Phosphorylation | EQKLALETTVLVESY HHHHHHEEEEEEEEE | 24.05 | - | |
238 | Phosphorylation | QKLALETTVLVESYT HHHHHEEEEEEEEEE | 11.49 | - | |
253 | Ubiquitination | LPDGRIIKVGGERFE CCCCCEEEECCEECC | 32.24 | 21906983 | |
253 | Acetylation | LPDGRIIKVGGERFE CCCCCEEEECCEECC | 32.24 | 25953088 | |
258 | Ubiquitination | IIKVGGERFEAPEAL EEEECCEECCCCHHH | 37.67 | 27667366 | |
298 | Phosphorylation | IDTRSEFYKHIVLSG CCCHHHHHHHHEECC | 9.52 | 25332170 | |
299 | Malonylation | DTRSEFYKHIVLSGG CCHHHHHHHHEECCC | 31.98 | 26320211 | |
299 | Acetylation | DTRSEFYKHIVLSGG CCHHHHHHHHEECCC | 31.98 | 19608861 | |
299 | Ubiquitination | DTRSEFYKHIVLSGG CCHHHHHHHHEECCC | 31.98 | 23000965 | |
304 | Ubiquitination | FYKHIVLSGGSTMYP HHHHHEECCCCCCCC | 30.16 | 23000965 | |
304 | Acetylation | FYKHIVLSGGSTMYP HHHHHEECCCCCCCC | 30.16 | 19608861 | |
304 | Phosphorylation | FYKHIVLSGGSTMYP HHHHHEECCCCCCCC | 30.16 | 25332170 | |
309 | Sulfoxidation | VLSGGSTMYPGLPSR EECCCCCCCCCCCHH | 3.99 | 30846556 | |
315 | O-linked_Glycosylation | TMYPGLPSRLERELK CCCCCCCHHHHHHHH | 55.32 | 30379171 | |
315 | Phosphorylation | TMYPGLPSRLERELK CCCCCCCHHHHHHHH | 55.32 | 25332170 | |
322 | Acetylation | SRLERELKQLYLERV HHHHHHHHHHHHHHH | 33.24 | 19608861 | |
322 | Ubiquitination | SRLERELKQLYLERV HHHHHHHHHHHHHHH | 33.24 | 21906983 | |
327 | Acetylation | ELKQLYLERVLKGDV HHHHHHHHHHHCCCH | 27.47 | 19608861 | |
327 | Ubiquitination | ELKQLYLERVLKGDV HHHHHHHHHHHCCCH | 27.47 | 27667366 | |
331 | Sumoylation | LYLERVLKGDVEKLS HHHHHHHCCCHHHHH | 50.65 | - | |
331 | Ubiquitination | LYLERVLKGDVEKLS HHHHHHHCCCHHHHH | 50.65 | 23000965 | |
331 | Succinylation | LYLERVLKGDVEKLS HHHHHHHCCCHHHHH | 50.65 | 23954790 | |
331 | Sumoylation | LYLERVLKGDVEKLS HHHHHHHCCCHHHHH | 50.65 | - | |
336 | Ubiquitination | VLKGDVEKLSKFKIR HHCCCHHHHHCCEEE | 58.89 | 23000965 | |
336 | Acetylation | VLKGDVEKLSKFKIR HHCCCHHHHHCCEEE | 58.89 | 25953088 | |
339 | Ubiquitination | GDVEKLSKFKIRIED CCHHHHHCCEEEECC | 62.20 | 24816145 | |
341 | Ubiquitination | VEKLSKFKIRIEDPP HHHHHCCEEEECCCC | 34.51 | 23000965 | |
344 | Ubiquitination | LSKFKIRIEDPPRRK HHCCEEEECCCCCCC | 8.85 | 24816145 | |
366 | Ubiquitination | AVLADIMKDKDNFWM HHHHHHHHCCCCCEE | 63.06 | 23000965 | |
368 | Ubiquitination | LADIMKDKDNFWMTR HHHHHHCCCCCEECH | 49.40 | 23000965 | |
368 | Acetylation | LADIMKDKDNFWMTR HHHHHHCCCCCEECH | 49.40 | 25953088 | |
371 | Ubiquitination | IMKDKDNFWMTRQEY HHHCCCCCEECHHHH | 7.27 | 23000965 | |
373 | Ubiquitination | KDKDNFWMTRQEYQE HCCCCCEECHHHHHH | 1.61 | 23000965 | |
374 | Phosphorylation | DKDNFWMTRQEYQEK CCCCCEECHHHHHHH | 21.57 | 21406692 | |
378 | Phosphorylation | FWMTRQEYQEKGVRV CEECHHHHHHHCCHH | 17.40 | - | |
381 | Neddylation | TRQEYQEKGVRVLEK CHHHHHHHCCHHHHH | 47.37 | 32015554 | |
381 | Acetylation | TRQEYQEKGVRVLEK CHHHHHHHCCHHHHH | 47.37 | 25953088 | |
381 | Ubiquitination | TRQEYQEKGVRVLEK CHHHHHHHCCHHHHH | 47.37 | 21906983 | |
386 | Ubiquitination | QEKGVRVLEKLGVTV HHHCCHHHHHHCCCC | 3.17 | 24816145 | |
386 | Neddylation | QEKGVRVLEKLGVTV HHHCCHHHHHHCCCC | 3.17 | 32015554 | |
388 | Sumoylation | KGVRVLEKLGVTVR- HCCHHHHHHCCCCC- | 46.51 | - | |
388 | Acetylation | KGVRVLEKLGVTVR- HCCHHHHHHCCCCC- | 46.51 | 27178108 | |
388 | Sumoylation | KGVRVLEKLGVTVR- HCCHHHHHHCCCCC- | 46.51 | - | |
388 | Ubiquitination | KGVRVLEKLGVTVR- HCCHHHHHHCCCCC- | 46.51 | 23000965 | |
393 | Ubiquitination | LEKLGVTVR------ HHHHCCCCC------ | 6.76 | 23000965 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
202 | Y | Phosphorylation | Kinase | MAP3K14 | Q99558 | GPS |
237 | T | Phosphorylation | Kinase | MAP3K14 | Q99558 | GPS |
237 | T | Phosphorylation | Kinase | PLK4 | O00444 | PSP |
238 | T | Phosphorylation | Kinase | MAP3K14 | Q99558 | GPS |
238 | T | Phosphorylation | Kinase | PLK4 | O00444 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARP2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-299 AND LYS-322, AND MASSSPECTROMETRY. |